Oscar Alvarez-Calderon-Iglesias

Prof. Oscar Alvarez-Calderon-Iglesias

Universidade da Coruña (UDC)
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
APAlejandro Ismael Lorenzo Pouso
Alejandro Ismael Lorenzo Pouso
APAlba Pérez-Jardón
Alba Pérez-Jardón
VCVITO CARLO ALBERTO CAPONIO
VITO CARLO ALBERTO CAPONIO
FSFrancesca Spirito
Francesca Spirito
CCCintia Chamorro
Cintia Chamorro
Mario Pérez-SayánsMario Pérez-Sayáns
Mario Pérez-Sayáns
Chronic hyperplastic candidiasis (CHC) is a prototypical oral lesion caused by chronic Candida infection. A major controversy surrounding CHC is whether this oral lesion owns malignant transformation (MT) potential. The aim of the present study was to evaluate current evidence on the MT of CHC and to determine the variables which have the greatest influence on cancer development. Bibliographical searches included PubMed, Embase, Web of Science, Scopus and LILACS. The cohort studies and case series used to investigate the MT of CHC were deemed suitable for inclusion. The quality of the enrolled studies was measured by the Joanna Briggs Institute scale. Moreover, we undertook subgroup analyses, assessed small study effects, and conducted sensitivity analyses. From 338 studies, nine were finally included for qualitative/quantitative analysis. The overall MT rate for CHC across all studies was 12.1% (95% confidential interval, 4.1–19.8%). Subgroup analysis showed that the MT rate increased when pooled analysis was restricted to poor quality studies. It remains complex to affirm whether CHC is an individual and oral, potentially malignant disorder according to the retrieved evidence. Prospective cohort studies to define the natural history of CHC and a consensus statement to clarify a proper set of diagnostic criteria are strongly needed. PROSPERO ID: CRD42022319572.

24 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAlejandro Ismael Lorenzo Pouso
Alejandro Ismael Lorenzo Pouso
JBJose Bagan
Jose Bagan
LBLeticia Bagán
Leticia Bagán
Pilar Gandara Gandara-VilaPilar Gandara Gandara-Vila
Pilar Gandara Gandara-Vila
CCCintia Chamorro
Cintia Chamorro
Mario Pérez-SayánsMario Pérez-Sayáns
Mario Pérez-Sayáns
Background: Nearly two decades have passed since a paradoxical reaction in the orofacial region to some bone modifying agents and other drugs was recognized, namely medication-related osteonecrosis of the jaw (MRONJ). Purpose: The aim of this manuscript was to critically review published data on MRONJ to provide an update on key terminology, concepts, and current trends in terms of prevention and diagnosis. In addition, our objective was to examine and evaluate the therapeutic options available for MRONJ. Methods: The authors perused the most relevant literature relating to MRONJ through a search in textbooks and published articles included in several databases for the years 2003–2021. Results and conclusions: A comprehensive update of the current understanding of these matters was elaborated, addressing these topics and identifying relevant gaps of knowledge. This review describes our updated view of the previous thematic blocks, highlights our current clinical directions, and emphasizes controversial aspects and barriers that may lead to extending the accumulating body of evidence related to this severe treatment sequela.

1 April 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
RHRafael Hurtado-Ruzza
Rafael Hurtado-Ruzza
OAOscar Alvarez-Calderon-Iglesias
Oscar Alvarez-Calderon-Iglesias
RDRaquel Dacal-Quintas
Raquel Dacal-Quintas
RVRicardo Becerro de Bengoa Vallejo
Ricardo Becerro de Bengoa Vallejo
César Calvo LoboCésar Calvo Lobo
César Calvo Lobo
Daniel López-LópezDaniel López-López
Daniel López-López
The goals of this study are to compare self-reported depression and anxiety in subjects diagnosed of asthma and healthy controls. We designed a case-control study. Subjects were recruited using a consecutive sampling method from a single institution. Two groups were created: Asthma and healthy controls. Data of medical history and demographic background were collected from the medical record. Self-reported depression level was assessed using Beck's depression inventory (BDI). Self-reported anxiety was measured with the "State-trait anxiety inventory" (STAI). Fifty-one subjects with asthma, and fifty healthy patients were included in this study. BDI scores (p<0.001) were higher for asthma (10.22±7.3) than in the control group (5.2±6.56). STAI state (p<0.001) was higher in asthma (42.61±11.5) than in controls (34.88±9.25). STAI trait (p<0.001) showed higher scores in asthma (43.14±10.89) than in controls (34.62±9.19). These study findings showed that BDI, and STAI trait and state scores are significantly higher in subjects who suffer from asthma than healthy controls.

2 February 2023 in Biology
Verified
Journal Article
Open access
PDF file
APAlejandro Ismael Lorenzo Pouso
Alejandro Ismael Lorenzo Pouso
FSFábio França Vieira e Silva
Fábio França Vieira e Silva
APAlba Pérez-Jardón
Alba Pérez-Jardón
CCCintia Chamorro
Cintia Chamorro
Mônica Ghislaine AlvesMônica Ghislaine Alves
Mônica Ghislaine Alves
Mario Pérez-SayánsMario Pérez-Sayáns
Mario Pérez-Sayáns
Oral squamous cell carcinoma (OSCC) is characterized by poor survival, mostly due to local invasion, loco-regional recurrence, and metastasis. Given that the weakening of cell-to-cell adhesion is a feature associated with the migration and invasion of cancer cells, different studies have explored the prognostic utility of cell adhesion molecules such as E-cadherin (E-cad). This study aims to summarize current evidence in a meta-analysis, focusing on the prognostic role of E-cad in OSCC. To find studies meeting inclusion criteria, Scopus, Web of Science, EMBASE, Medline, and OpenGrey databases were systematically assessed and screened. The selection process led to 25 studies, which were considered eligible for inclusion in the meta-analysis, representing a sample of 2553 patients. E-cad overexpression was strongly associated with longer overall survival (OS) with Hazard Ratio (HR) = 0.41 95% confidence interval (95% CI) (0.32–0.54); p < 0.001 and disease-free survival with HR 0.47 95% CI (0.37–0.61); p < 0.001. In terms of OS, patients with tongue cancer experienced better survivability when expressing E-cad with HR 0.28 95% CI (0.19–0.43); p < 0.001. Globally, our findings indicate the prognostic role of the immunohistochemical assessment of E-cad in OSCC and its expression might acquire a different role based on the oral cavity subsites.

1 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
APAlejandro Ismael Lorenzo Pouso
Alejandro Ismael Lorenzo Pouso
MGMercedes Gallas-Torreira
Mercedes Gallas-Torreira
Mario Pérez-SayánsMario Pérez-Sayáns
Mario Pérez-Sayáns
CCCintia Chamorro
Cintia Chamorro
OAOscar Alvarez-Calderon-Iglesias
Oscar Alvarez-Calderon-Iglesias
AGAbel Garcia-Garcia
Abel Garcia-Garcia
Carbonic anhydrase IX (CAIX) is a hypoxia-related protein considered as a predictor for oral squamous cell carcinoma (OSCC) biological behaviour. Nevertheless, this prognostic value is still yet to be validated. We aim to quantify prognostic significance of CAIX overexpression in OSCC by meta-analysis. We performed searches in MEDLINE, EMBASE, SCOPUS, WOS, WHO’S databases, CPCI, and OATD from inception to August 2019. Overall survival (OS), disease-free survival (DFS), locoregional control (LC), and disease-specific survival (DSS) were considered as outcomes of interest. Overall 18 studies were included. CAIX overexpression was associated with worse OS (hazard ratio [HR] = 1.45 95% confidence interval [CI] 1.17–1.80) and DFS (HR = 1.98 95% CI 1.18–3.32). To the contrary, it was neither associated with LC (HR = 1.01 95% CI 0.50–2.02) nor with DSS (HR = 1.35 95% CI 0.78–2.33). Heterogeneity was negligible in all analyses except for DSS. Small studies effect was not significant for OS and DFS. This study shows that immunohistochemical CAIX assessment is a useful OSCC prognostic biomarker.

21 February 2022 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
RHRafael Hurtado-Ruzza
Rafael Hurtado-Ruzza
OAOscar Alvarez-Calderon-Iglesias
Oscar Alvarez-Calderon-Iglesias
RVRicardo Becerro de Bengoa Vallejo
Ricardo Becerro de Bengoa Vallejo
César Calvo LoboCésar Calvo Lobo
César Calvo Lobo
MAMarta San Antolín-Gil
Marta San Antolín-Gil
Daniel López-LópezDaniel López-López
Daniel López-López
Anxiety and depression are the most prevalent mental disorders worldwide. However, the exact mechanisms linking chronic obstructive pulmonary disease (COPD) with depression and anxiety have not been identified. To compare self-reported depression and anxiety among patients diagnosed with COPD in relation to healthy controls. Case control study at a public hospital institution in Spain. We designed a case-control study. Patients were recruited using a consecutive sampling method from a single institution. Two groups were created: COPD and healthy controls. Data on medical history and demographic background were collected from the medical records. Self-reported depression levels were assessed using Beck’s depression inventory (BDI). Self-reported anxiety was measured using the State-trait anxiety inventory (STAI). Fifty-two patients with COPD and fifty healthy patients were included in this study. BDI scores were higher for COPD patients (10.23 ± 6.26) than in the control group (5.2 ± 6.56). STAI-state scores were higher for COPD patients (41.85 ± 12.55) than for controls (34.88 ± 9.25). STAI-trait scores were higher for COPD patients (41.42 ± 10.01) than for controls (34.62 ± 9.19). This study showed that there were higher levels of depression and anxiety among COPD patients than among healthy controls.